KWEB vs. XBI
KWEB (KraneShares CSI China Internet ETF) and XBI (SPDR S&P Biotech ETF) are both exchange-traded funds - KWEB is a China Equities fund tracking the CSI Overseas China Internet Index, while XBI is a Health & Biotech Equities fund tracking the S&P Biotechnology Select Industry Index. Both are passively managed. Over the past 10 years, KWEB returned -0.22%/yr vs 10.74%/yr for XBI. At a 0.42 correlation, their price movements are largely independent. KWEB charges 0.70%/yr vs 0.35%/yr for XBI.
Performance
KWEB vs. XBI - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, KWEB achieves a -21.26% return, which is significantly lower than XBI's 26.64% return. Over the past 10 years, KWEB has underperformed XBI with an annualized return of -0.22%, while XBI has yielded a comparatively higher 10.74% annualized return.
KWEB
- 1D
- -2.44%
- 1M
- 5.63%
- 6M
- -24.92%
- YTD
- -21.26%
- 1Y
- -20.35%
- 3Y*
- 2.29%
- 5Y*
- -12.28%
- 10Y*
- -0.22%
XBI
- 1D
- 1.49%
- 1M
- 10.78%
- 6M
- 24.34%
- YTD
- 26.64%
- 1Y
- 75.86%
- 3Y*
- 21.96%
- 5Y*
- 4.27%
- 10Y*
- 10.74%
KWEB vs. XBI - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
KWEB KraneShares CSI China Internet ETF | -21.26% | 23.55% | 12.01% | -9.06% | -17.24% | -49.01% | 58.23% | 29.92% | -33.80% | 69.73% |
XBI SPDR S&P Biotech ETF | 26.64% | 35.89% | 1.01% | 7.60% | -25.87% | -20.45% | 48.33% | 32.56% | -15.28% | 43.77% |
Correlation
The correlation between KWEB and XBI is 0.26, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.26 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.30 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.37 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.41 |
Correlation (All Time) Calculated using the full available price history since Aug 1, 2013 | 0.42 |
The correlation between KWEB and XBI shifts across timeframes, from 0.26 (1 year) to 0.42 (all time), reflecting how their relationship changes across market environments.
KWEB vs. XBI - Sectors Allocation Comparison
Sectors
KWEB
XBI
Consumer Cyclical
-
Communication Services
-
Technology
-
Healthcare
Industrials
-
Real Estate
-
Consumer Defensive
-
Financial Services
Basic Materials
-
Energy
-
-
Utilities
-
-
Consumer Cyclical
KWEB
XBI
-
Communication Services
KWEB
XBI
-
Technology
KWEB
XBI
-
Healthcare
KWEB
XBI
Industrials
KWEB
XBI
-
Real Estate
KWEB
XBI
-
Consumer Defensive
KWEB
XBI
-
Financial Services
KWEB
XBI
Basic Materials
KWEB
-
XBI
Energy
KWEB
-
XBI
-
Utilities
KWEB
-
XBI
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
KWEB vs. XBI — Risk / Return Rank
KWEB
XBI
KWEB vs. XBI - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for KraneShares CSI China Internet ETF (KWEB) and SPDR S&P Biotech ETF (XBI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| KWEB | XBI | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -3.61 | ||
| Sortino ratioReturn per unit of downside risk | -4.66 | ||
| Omega ratioGain probability vs. loss probability | 0.89 | 1.44 | -0.55 |
| Calmar ratioReturn relative to maximum drawdown | -0.49 | 7.84 | -8.33 |
| Martin ratioReturn relative to average drawdown | -0.97 | 22.59 | -23.56 |
Loading charts...
Drawdowns
KWEB vs. XBI - Drawdown Comparison
The maximum KWEB drawdown since its inception was -80.92%, which is greater than XBI's maximum drawdown of -63.89%. Use the drawdown chart below to compare losses from any high point for KWEB and XBI.
Loading charts...
Drawdown Indicators
| KWEB | XBI | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -80.92% | -63.89% | -17.03% |
Max Drawdown (1Y)Largest decline over 1 year | -41.62% | -9.72% | -31.90% |
Max Drawdown (3Y)Largest decline over 3 years | -41.62% | -32.99% | -8.63% |
Max Drawdown (5Y)Largest decline over 5 years | -67.58% | -54.00% | -13.58% |
Max Drawdown (10Y)Largest decline over 10 years | -80.92% | -63.89% | -17.03% |
Current DrawdownCurrent decline from peak | -68.99% | -10.75% | -58.24% |
Average DrawdownAverage peak-to-trough decline | -35.55% | -20.89% | -14.66% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 21.01% | 3.38% | +17.63% |
Volatility
KWEB vs. XBI - Volatility Comparison
KraneShares CSI China Internet ETF (KWEB) and SPDR S&P Biotech ETF (XBI) have volatilities of 8.34% and 8.43%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| KWEB | XBI | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.34% | 8.43% | -0.09% |
Volatility (6M)Calculated over the trailing 6-month period | 20.26% | 21.44% | -1.18% |
Volatility (1Y)Calculated over the trailing 1-year period | 27.55% | 26.60% | +0.95% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 47.59% | 32.33% | +15.26% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 40.01% | 31.94% | +8.07% |
KWEB vs. XBI - Expense Ratio Comparison
KWEB has a 0.70% expense ratio, which is higher than XBI's 0.35% expense ratio.
Dividends
KWEB vs. XBI - Dividend Comparison
KWEB's dividend yield for the trailing twelve months is around 7.82%, more than XBI's 0.37% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
KWEB KraneShares CSI China Internet ETF | 7.82% | 6.16% | 3.51% | 1.71% | 0.00% | 7.07% | 0.29% | 0.08% | 3.40% | 0.58% | 1.19% | 0.46% |
XBI SPDR S&P Biotech ETF | 0.37% | 0.37% | 0.15% | 0.02% | 0.00% | 0.04% | 0.20% | 0.00% | 0.28% | 0.24% | 0.26% | 0.61% |
Frequently Asked Questions
KWEB and XBI have a correlation of 0.26, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
XBI has higher volatility (8.43%) compared to KWEB (8.34%). In terms of maximum drawdown, KWEB dropped -80.92% vs XBI's -63.89%.
On 10-year performance, XBI leads with 10.74% vs -0.22% for KWEB. On fees, XBI is cheaper at 0.35% per year. Their volatility is very similar. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, XBI has performed better with a 10.74% return vs -0.22%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
XBI is cheaper with a 0.35% expense ratio, compared with 0.70% for KWEB.
KWEB has the higher dividend yield at 7.82%, compared with 0.37% for XBI.
KWEB is categorized as China Equities, while XBI is Health & Biotech Equities. KWEB tracks CSI Overseas China Internet Index, while XBI tracks S&P Biotechnology Select Industry Index. They also come from different issuers: KraneShares and State Street. Their fees differ too: 0.70% for KWEB and 0.35% for XBI.
XBI currently has the higher Sharpe Ratio (2.87 vs -0.74), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for KWEB and XBI
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer